- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
MBLX Market Currents
more »
-
April 26 Metabolix (MBLX): Q1 EPS of $0.84 in-line. Revenue of $39.3M (+11924% Y/Y) in-line. (PR)
Comment![Earnings, Healthcare]
MBLX in Focus
more »
-
-
-
-
Tue, Nov 1, 2011 • Comment!
-
Wed, Apr 27, 2011 • 6 Comments
MBLX Related Articles
more »
MBLX News
more »
-
at CNBC.com (Jan 13, 2012)
-
at MarketWatch.com (Jan 13, 2012)
-
at MarketWatch.com (Jan 13, 2012)
-
at CNBC.com (Jan 13, 2012)
-
at MarketWatch.com (Jan 13, 2012)
MBLX Press Releases and Filings
more »
-
Business Wire (May 3, 2012)
-
Business Wire (Apr 26, 2012)
-
Business Wire (Apr 25, 2012)
-
Business Wire (Apr 23, 2012)
-
Business Wire (Apr 23, 2012)
MBLX Latest Transcript
more »
MBLX Cramer
more »
-
Tue, Oct 16, 2007
-
Fri, May 11, 2007
MBLX Instablog posts
more »
MBLX vs. ETF Alternatives
Company Description
We are a bioscience company that develops and is in the process of commercializing environmentally sustainable, economically attractive alternatives to petroleum-based plastics, with work underway to do the same with chemicals and energy. We have core capabilities in microbial genetics,... More
